Free Trial

EUROFINS SCIENT (OTCMKTS:ERFSF) Stock Price Down 3.2% - Should You Sell?

EUROFINS SCIENT logo with Medical background

Key Points

  • The shares of EUROFINS SCIENT fell by 3.2% on Wednesday, trading at $73.40, with a notable decrease in trading volume.
  • Analysts have mainly given the stock a neutral rating, with one strong buy and five hold ratings reflecting a current average rating of "Hold."
  • EUROFINS SCIENT has a solid financial structure with a current ratio of 1.26 and a debt-to-equity ratio of 0.77, indicating good liquidity and manageable debt levels.
  • MarketBeat previews the top five stocks to own by November 1st.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report) dropped 3.2% during trading on Wednesday . The stock traded as low as $73.40 and last traded at $73.40. Approximately 245 shares changed hands during trading, a decline of 84% from the average daily volume of 1,500 shares. The stock had previously closed at $75.84.

Wall Street Analyst Weigh In

Separately, Citigroup reiterated a "neutral" rating on shares of EUROFINS SCIENT in a report on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold".

Read Our Latest Report on EUROFINS SCIENT

EUROFINS SCIENT Stock Up 1.9%

The firm's 50-day moving average is $76.18 and its 200 day moving average is $67.10. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19.

About EUROFINS SCIENT

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Read More

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.